CPS
Foundational Level
If you’re new to PD-L1 scoring, you’ve come to the right place! Browse all foundational training resources on the CDx Digital Education Portal here.
PD-L1 IHC 22C3 pharmDx Interpretation Training Program for Esophageal Squamous Cell Carcinoma (ESCC)
PD-L1 IHC 22C3 pharmDx Interpretation Training Program for Head and Neck Squamous Cell Carcinoma (HNSCC)
PD-L1 IHC 22C3 pharmDx Interpretation Training Program for Non-Small Cell Lung Cancer (NSCLC)
PD-L1 IHC 22C3 pharmDx Interpretation Training Program for Triple-Negative Breast Cancer (TNBC)
PD-L1 IHC 22C3 pharmDx Interpretation Manual for Esophageal Squamous Cell Carcinoma (ESCC)
PD-L1 IHC 22C3 pharmDx Interpretation Manual for Head and Neck Squamous Cell Carcinoma (HNSCC)
PD-L1 IHC 22C3 pharmDx Quick Scoring Guide for Head and Neck Squamous Cell Carcinoma (HNSCC)
Assessing PD-L1 Combined Positive Score (CPS) in Various Tumor Types with Distinct Morphological Characteristics
Implementation of PD-L1 Testing in the New Era of an Everchanging Immuno-oncology Landscape
The Rationale Behind the Scoring Systems for PD-L1 IHC to Determine Patients Eligible for KEYTRUDA (pembrolizumab)
D72594_01